Skip to content

Acute trauma patients after operation were used Ketorolac Tromethamine Injection combined with sufentanil for patient evaluation of patient-controlled intravenous analgesia (PCIA) intensity, sedative effect, adverse reaction and more frugal opioid effect observed on the type of pain and quality of life differences

Acute trauma patients after operation were used Ketorolac Tromethamine Injection combined with sufentanil for patient evaluation of patient-controlled intravenous analgesia (PCIA) intensity, sedative effect, adverse reaction and more frugal opioid effect observed on the type of pain and quality of life differences

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006725
Enrollment
Unknown
Registered
2015-07-10
Start date
2015-07-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia of Trauma operation

Interventions

The test group and control group:Ketorolac Tromethamine Injection combined with sufentanil versus sufentanil

Sponsors

Jinshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. the subjects: anesthesia after operation in patients undergoing general; 2. the degree of pain: pain when reaching or severe patients regained consciousness after operation; 3. age: 18 to 65 years old, male or female; 4. weight: 50 to 70kg; 5. heart, liver function is normal, renal function and blood coagulation function of normal; 6. volunteers, and written informed consent was obtained.

Exclusion criteria

Exclusion criteria: 1. pregnant and lactating women; 2. for NSAID drugs have a history of allergy and high allergy; 3. have a history of asthma; 4. In an unexpected situation or operation time in operation were significantly lengthened; 5. With digestive tract ulcer or hemorrhage in past six months; 6. In past 2 weeks, received NSAID therapy is used; drug interactions and ketorolac ammonia butyl alcohol three (such as: phenytoin, C Masi Bing, non depolarizing muscle relaxants such as curare etc.); 7. can not be described the response to the treatment of disease or mental disorder patients; 8. with coagulation diseases; 9. in the past 3 months participated in other drug test; 10. The degree of pain after operation 10, lower than the moderate; 11. poor compliance of patients; 12. the analgesic and alcohol dependent patients; 13. the amount of intraoperative bleeding is more than or equal to 1500ml.

Design outcomes

Primary

MeasureTime frame
VAS;Pain intensity, PI;Dizziness, nausea and vomiting;

Countries

China

Contacts

Public ContactFang Hao
drfanghao@163.com+86 18918726329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026